Inotiv Inc is a leading provider of preclinical and clinical research services, specializing in laboratory animal research and drug development solutions for the pharmaceutical and biotechnology industries. The company offers a wide range of scientific services, including toxicology, pathology, and pharmacology, aimed at helping clients navigate the complexities of medical research and bring new therapies to market. By leveraging advanced technologies and expertise, Inotiv supports clients in designing and executing studies that ensure the safety and efficacy of therapeutic products, thereby advancing healthcare innovation. Read More
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Inotiv, Inc. (NASDAQ: NOTV) breached their fiduciary duties to shareholders.
Sea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system)
Insider buying is a signal to buy for two of the stocks on this list, insider selling raises a red flag for the other but doesn't offset institutional activity.
The law firm of Kirby McInerney LLP is investigating potential claims against Inotiv, Inc. (“Inotiv” or the “Company”) (NASDAQ: NOTV). The investigation concerns whether Inotiv and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
